Connection
Christopher Lieu to Maximum Tolerated Dose
This is a "connection" page, showing publications Christopher Lieu has written about Maximum Tolerated Dose.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.291 |
|
|
|
-
Lieu CH, Lenz HJ, Benson AB, Meng X, Kim UI, Kim SH, Kim K, Sung MJ. A First-In-Human Dose-Escalation Phase I Study of Basroparib, a Tankyrase Inhibitor, in Patients with Advanced-Stage Solid Tumors. Cancer Res Commun. 2025 10 01; 5(10):1771-1778.
Score: 0.223
-
Lieu C, Chow L, Pierson AS, Eckhardt SG, O'Bryant CL, Morrow M, Tran ZV, Wright JJ, Gore L. A phase I study of bortezomib, etoposide and carboplatin in patients with advanced solid tumors refractory to standard therapy. Invest New Drugs. 2009 Feb; 27(1):53-62.
Score: 0.068